{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:14:29Z","timestamp":1765995269884,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100011733","name":"Liga Portuguesa Contra o Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100011733","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iNOVA4Health Research Unit","award":["UIDP\/04462\/2020; UI\/BD\/154256\/2022","LISBOA-01-0145-FEDER-007344; UID\/Multi\/00462; UIDB\/04462\/2020","LISBOA-01-0145-FEDER-007344; UID\/Multi\/00462; UIDB\/04462\/2020"],"award-info":[{"award-number":["UIDP\/04462\/2020; UI\/BD\/154256\/2022","LISBOA-01-0145-FEDER-007344; UID\/Multi\/00462; UIDB\/04462\/2020","LISBOA-01-0145-FEDER-007344; UID\/Multi\/00462; UIDB\/04462\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03633-y","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T04:24:34Z","timestamp":1702700674000},"page":"625-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes"],"prefix":"10.1007","volume":"84","author":[{"given":"Joana","family":"Sim\u00f5es-Pereira","sequence":"first","affiliation":[]},{"given":"Ana","family":"Saramago","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Pojo","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Horta","sequence":"additional","affiliation":[]},{"given":"Dolores","family":"L\u00f3pez-Presa","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Rito","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"Cabrera","sequence":"additional","affiliation":[]},{"given":"Teresa C.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Valeriano","family":"Leite","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8946-8635","authenticated-orcid":false,"given":"Branca M.","family":"Cavaco","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"3633_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"J.A. Fagin, S.A. Wells, Biologic and clinical perspectives on thyroid cancer. N. Engl. J. Med. 375, 1054\u20131067 (2016)","journal-title":"N. Engl. J. Med."},{"key":"3633_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1\u2013133 (2016)","journal-title":"Thyroid"},{"key":"3633_CR3","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892\u20132899 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3633_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"R.M. Tuttle, S. Ahuja, A.M. Avram, V.J. Bernet, P. Bourguet, G.H. Daniels, G. Dillehay, C. Draganescu, G. Flux, D. F\u00fchrer, L. Giovanella, B. Greenspan, M. Luster, K. Muylle, J.W.A. Smit, D. Van Nostrand, F.A. Verburg, L. Heged\u00fcs, Controversies, Consensus, and Collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of nuclear medicine, the society of nuclear medicine and molecular imaging, and the European Thyroid Association. Thyroid 29, 461\u2013470 (2019)","journal-title":"Thyroid"},{"key":"3633_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network., Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014)","journal-title":"Cell"},{"key":"3633_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"N Pozdeyev","year":"2018","unstructured":"N. Pozdeyev, L.M. Gay, E.S. Sokol, R. Hartmaier, K.E. Deaver, S. Davis, J.D. French, P.V. Borre, D.V. LaBarbera, A.C. Tan, R.E. Schweppe, L. Fishbein, J.S. Ross, B.R. Haugen, D.W. Bowles, Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin. Cancer Res. 24, 3059\u20133068 (2018)","journal-title":"Clin. Cancer Res."},{"key":"3633_CR7","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","volume":"23","author":"T Ibrahimpasic","year":"2017","unstructured":"T. Ibrahimpasic, B. Xu, I. Landa, S. Dogan, S. Middha, V. Seshan, S. Deraje, D.L. Carlson, J. Migliacci, J.A. Knauf, B. Untch, M.F. Berger, L. Morris, R.M. Tuttle, T. Chan, J.A. Fagin, R. Ghossein, I. Ganly, Genomic alterations in fatal forms of non-anaplastic thyroid cancer: identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence. Clin. Cancer Res. 23, 5970\u20135980 (2017)","journal-title":"Clin. Cancer Res."},{"key":"3633_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126, 1052\u20131066 (2016)","journal-title":"J. Clin. Invest."},{"key":"3633_CR9","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","volume":"24","author":"JW Kunstman","year":"2015","unstructured":"J.W. Kunstman, C.C. Juhlin, G. Goh, T.C. Brown, A. Stenman, J.M. Healy, J.C. Rubinstein, M. Choi, N. Kiss, C. Nelson-Williams, S. Mane, D.L. Rimm, M.L. Prasad, A. H\u00f6\u00f6g, J. Zedenius, C. Larsson, R. Korah, R.P. Lifton, T. Carling, Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum. Mol. Genet. 24, 2318\u20132329 (2015)","journal-title":"Hum. Mol. Genet."},{"key":"3633_CR10","doi-asserted-by":"publisher","first-page":"E829","DOI":"10.1210\/jc.2012-3933","volume":"98","author":"MM Sabra","year":"2013","unstructured":"M.M. Sabra, J.M. Dominguez, R.K. Grewal, S.M. Larson, R.A. Ghossein, R.M. Tuttle, J.A. Fagin, Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. J. Clin. Endocrinol. Metab 98, E829\u2013E836 (2013)","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"3633_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1089\/thy.2019.0075","volume":"29","author":"L Shobab","year":"2019","unstructured":"L. Shobab, C. Gomes-Lima, A. Zeymo, R. Feldman, J. Jonklaas, L. Wartofsky, K.D. Burman, Clinical, pathological, and molecular profiling of radioactive iodine refractory differentiated thyroid cancer. Thyroid 29, 1262\u20131268 (2019)","journal-title":"Thyroid"},{"key":"3633_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","volume":"34","author":"I Ganly","year":"2018","unstructured":"I. Ganly, V. Makarov, S. Deraje, Y. Dong, E. Reznik, V. Seshan, G. Nanjangud, S. Eng, P. Bose, F. Kuo, L.G.T. Morris, I. Landa, P.B. Carrillo Albornoz, N. Riaz, Y.E. Nikiforov, K. Patel, C. Umbricht, M. Zeiger, E. Kebebew, E. Sherman, R. Ghossein, J.A. Fagin, T.A. Chan, Integrated genomic analysis of h\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell 34, 256\u2013270 (2018)","journal-title":"Cancer Cell"},{"key":"3633_CR13","doi-asserted-by":"publisher","first-page":"e3911","DOI":"10.1210\/clinem\/dgab436","volume":"106","author":"J Sim\u00f5es-Pereira","year":"2021","unstructured":"J. Sim\u00f5es-Pereira, N. Mourinho, T.C. Ferreira, E. Limbert, B.M. Cavaco, V. Leite, Avidity and outcomes of radioiodine therapy for distant metastasis of distinct types of differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 106, e3911\u2013e3922 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3633_CR14","doi-asserted-by":"publisher","first-page":"L7","DOI":"10.1530\/ERC-17-0453","volume":"25","author":"L Lamartina","year":"2018","unstructured":"L. Lamartina, G. Grani, E. Arvat, A. Nervo, M.C. Zatelli, R. Rossi, E. Puxeddu, S. Morelli, M. Torlontano, M. Massa, R. Bellantone, A. Pontecorvi, T. Montesano, L. Pagano, L. Daniele, L. Fugazzola, G. Ceresini, R. Bruno, R. Rossetto, S. Tumino, M. Centanni, D. Meringolo, M.G. Castagna, D. Salvatore, A. Nicolucci, G. Lucisano, S. Filetti, C. Durante, 8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr. Relat. Cancer 25, L7\u2013L11 (2018)","journal-title":"Endocr. Relat. Cancer"},{"key":"3633_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009)","journal-title":"Eur. J. Cancer"},{"key":"3633_CR16","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/er.2019-00007","volume":"40","author":"ME Cabanillas","year":"2019","unstructured":"M.E. Cabanillas, M. Ryder, C. Jimenez, Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocr. Rev. 40, 1573\u20131604 (2019)","journal-title":"Endocr. Rev."},{"key":"3633_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/thy.2018.0048","volume":"28","author":"Van Nostrand.","year":"2018","unstructured":"Van Nostrand., Radioiodine refractory differentiated thyroid cancer: time to update the classifications. Thyroid 28, 1083\u20131093 (2018)","journal-title":"Thyroid"},{"key":"3633_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06900-7","volume":"20","author":"SH Malgundkar","year":"2020","unstructured":"S.H. Malgundkar, I. Burney, M. Al Moundhri, M. Al Kalbani, R. Lakhtakia, A. Okamoto, Y. Tamimi, FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and \u03b2-catenin activity in ovarian cancer. BMC Cancer 20, 374 (2020)","journal-title":"BMC Cancer"},{"key":"3633_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1530\/EJE-18-0653","volume":"180","author":"K van der Tuin","year":"2019","unstructured":"K. van der Tuin, M. Ventayol Garcia, W.E. Corver, M.N. Khalifa, D. Ruano Neto, E.P.M. Corssmit, F.J. Hes, T.P. Links, J.W.A. Smit, T.S. Plantinga, E. Kapiteijn, T. van Wezel, H. Morreau, Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma. Eur. J. Endocrinol. 180, 235\u2013241 (2019)","journal-title":"Eur. J. Endocrinol."},{"key":"3633_CR20","doi-asserted-by":"publisher","first-page":"e2346","DOI":"10.1210\/clinem\/dgaa246","volume":"105","author":"NM I\u00f1iguez-Ariza","year":"2020","unstructured":"N.M. I\u00f1iguez-Ariza, S. Jasim, M.M. Ryder, A.V. Chintakuntlawar, J.C. Morris, C.R. Hilger, M.E. Menefee, R.C. Smallridge, N.J. Karlin, C. Alcaino, K.C. Bible, Foundation one genomic interrogation of thyroid cancers in patients with metastatic disease requiring systemic therapy. J. Clin. Endocrinol. Metab. 105, e2346\u2013e2357 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3633_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/ERC-19-0452","volume":"27","author":"E Song","year":"2020","unstructured":"E. Song, D.E. Song, J. Ahn, T.Y. Kim, W.B. Kim, Y.K. Shong, M.J. Jeon, W.G. Kim, Genetic profile of advanced thyroid cancers in relation to distant metastasis. Endocr. Relat. Cancer 27, 285\u2013293 (2020)","journal-title":"Endocr. Relat. Cancer"},{"key":"3633_CR22","doi-asserted-by":"publisher","first-page":"623182","DOI":"10.3389\/fendo.2021.623182","volume":"12","author":"CJ Gomes-Lima","year":"2021","unstructured":"C.J. Gomes-Lima, L. Shobab, D. Wu, D. Ylli, A. Bikas, M. McCoy, R. Feldman, W. Lee, S.N. Rao, K. Jensen, V. Vasko, L.C. Castro, J. Jonklaas, L. Wartofsky, K.D. Burman, Do molecular profiles of primary versus metastatic radioiodine refractory differentiated thyroid cancer differ? Front. Endocrinol. 12, 623182 (2021)","journal-title":"Front. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03633-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03633-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03633-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:21:49Z","timestamp":1715062909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03633-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["3633"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03633-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The collection of biological samples from all subjects involved in this study was performed after written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethical Committee of IPOLFG (approval number 1056).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}